IS4617A - Notkun alendrónats til að fyrirbyggja beingisnun - Google Patents

Notkun alendrónats til að fyrirbyggja beingisnun

Info

Publication number
IS4617A
IS4617A IS4617A IS4617A IS4617A IS 4617 A IS4617 A IS 4617A IS 4617 A IS4617 A IS 4617A IS 4617 A IS4617 A IS 4617A IS 4617 A IS4617 A IS 4617A
Authority
IS
Iceland
Prior art keywords
alendronate
prevent osteoporosis
osteoporosis
prevent
Prior art date
Application number
IS4617A
Other languages
English (en)
Icelandic (is)
Inventor
J. Yates Ashley
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of IS4617A publication Critical patent/IS4617A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS4617A 1995-06-02 1997-11-19 Notkun alendrónats til að fyrirbyggja beingisnun IS4617A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02
PCT/US1996/007912 WO1996038156A1 (en) 1995-06-02 1996-05-29 Use of alendronate for the prevention of osteoporosis

Publications (1)

Publication Number Publication Date
IS4617A true IS4617A (is) 1997-11-19

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4617A IS4617A (is) 1995-06-02 1997-11-19 Notkun alendrónats til að fyrirbyggja beingisnun

Country Status (21)

Country Link
EP (1) EP0828496A1 (ja)
JP (1) JPH10506648A (ja)
KR (1) KR19990022436A (ja)
CN (1) CN1192685A (ja)
AU (1) AU709196B2 (ja)
BG (1) BG63103B1 (ja)
BR (1) BR9609020A (ja)
CA (1) CA2222318A1 (ja)
CZ (1) CZ381197A3 (ja)
EA (1) EA000677B1 (ja)
EE (1) EE03306B1 (ja)
HU (1) HUP9900659A3 (ja)
IL (1) IL118422A0 (ja)
IS (1) IS4617A (ja)
NO (1) NO975527D0 (ja)
NZ (1) NZ308935A (ja)
PL (1) PL323669A1 (ja)
SK (1) SK159597A3 (ja)
TR (1) TR199701482T1 (ja)
WO (1) WO1996038156A1 (ja)
ZA (1) ZA964465B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
PT1392325E (pt) * 2001-05-02 2006-10-31 Novartis Ag Metodo de administracao de bifosfonatos por inalacao no tratamento ou na prevencao da reabsorcao ossea e da osteoporose
JP2010043119A (ja) * 2009-10-16 2010-02-25 Gador Sa 骨の代謝病の予防および/または治療のための組成物、その組成物の調製方法およびその使用
KR102472749B1 (ko) * 2022-01-18 2022-12-02 주식회사 위엔씨 유해가스제거 및 항균탈취기능을 함유한 흡착소재 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
CA2222318A1 (en) 1996-12-05
AU5882496A (en) 1996-12-18
NO975527L (no) 1997-12-01
NZ308935A (en) 2000-07-28
AU709196B2 (en) 1999-08-26
KR19990022436A (ko) 1999-03-25
SK159597A3 (en) 1998-06-03
EP0828496A1 (en) 1998-03-18
HUP9900659A2 (hu) 2001-04-28
BR9609020A (pt) 1999-07-06
BG102060A (en) 1998-07-31
BG63103B1 (bg) 2001-04-30
CN1192685A (zh) 1998-09-09
HUP9900659A3 (en) 2002-12-28
TR199701482T1 (xx) 1998-03-21
PL323669A1 (en) 1998-04-14
EA000677B1 (ru) 2000-02-28
CZ381197A3 (cs) 1998-06-17
NO975527D0 (no) 1997-12-01
IL118422A0 (en) 1996-09-12
ZA964465B (en) 1996-12-11
JPH10506648A (ja) 1998-06-30
WO1996038156A1 (en) 1996-12-05
EE03306B1 (et) 2000-12-15
EA199700449A1 (ru) 1998-06-25

Similar Documents

Publication Publication Date Title
FR2729849B1 (fr) Pansement adhesif
DE69811054D1 (de) Verpackung von folienartigen pflaster
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
ID19439A (id) Peningkatan pada senyawa organik atau yang terkait
NO952986D0 (no) Anordning til innbyrdes befestigelse av to innretninger
IT1276799B1 (it) Formulazioni di f-silicone
IS4617A (is) Notkun alendrónats til að fyrirbyggja beingisnun
EE9900113A (et) Vedelad alendronaatpreparaadid
FI952707A0 (fi) Syöttöveden esilämmitinjärjestelmä
ID17424A (id) Penghambat matriks metaloproteasa oleh senyawa-senyawa fenetil tersubstitusi
DK0721929T3 (da) Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner
NO980862D0 (no) Zwitterinoformer av trovafloxacin
DE59601357D1 (de) Neue Flüssigformulierungen
DK0863874T3 (da) Fremgangsmåde til fremstilling af dioxoazabicyclohexaner
ATA93795A (de) Befestigungsbinder
NO964685D0 (no) Isomering av equilin
KR960031589U (ko) 보차도 경계석의 연결구
PT761766E (pt) Compostos assimetricos de trifenilenodioxazina
KR960031694U (ko) 콘크리트로 만든 폼타이용 콘-넛트
AT204U3 (de) Fussabstreifer
KR970000111U (ko) 도계 설비 시스템의 3차 이양기
KR970010637U (ko) 물분배기의 개폐장치
KR970015931U (ko) 분리형 신발
KR960027282U (ko) 건축 도장용 주걱
SE9502977D0 (sv) Sätt att modulera